Hims & Hers Raises Annual Revenue Guidance to $3.3B Despite Q2 Loss

Key Facts

Amid the rapid expansion of the digital healthcare sector, Hims & Hers results demonstrated a notable divergence between robust revenue growth and net profitability. According to analyst reports, the company raised its full-year revenue guidance to a range of $3.1 billion to $3.3 billion, while Q2 revenue reached $753.21 million, significantly surpassing the $698.89 million expectation. However, the platform reported an EPS loss of $0.10, double the $0.05 loss anticipated by analysts.

This guidance update surpasses the previous range of $2.8 billion to $3 billion, suggesting growth momentum that exceeds initial estimates despite margin pressures. Financial indicators show a price-to-sales (P/S) ratio of 2.75 and a debt-to-equity ratio of 4.77, reflecting a financing structure that relies notably on leverage to fund expansion. These metrics are pivotal for investors evaluating spending efficiency against the pace of market share acquisition.

Based on available data, specific price levels for the stock are currently unavailable in the database, necessitating the monitoring of qualitative price movements in upcoming sessions. Traders should also keep an eye on broader US economic data; for instance, JOLTs data released on August 4, 2026, showed job openings at 7.359 million, which may influence general market sentiment toward consumer and tech stocks.